Notable Labs

IPO

Personalized drug discovery for blood cancer.

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$77.4M
Last Round
$10.3M Venture RoundFeb 2023
Rounds
5
Type
Public

About

Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single drug can lead to resistant clones or relapse. We're building a highly automated lab in Foster City running on our custom software and are currently testing relapsed/refractory cancer patients as well as samples from a variety of pharma/biotech partnerships. https://www.notablelabs.com/careers

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Venture UnknownPIPE FinancingFeb 2023
$10.3M

Sign up to see all 5 rounds

Full funding history, per-round amounts, and investor participation.

Create Free Account

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies